← Eichor
Condition: Uterine Fibroids With Menorrhagia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Uterine Fibroids With Menorrhagia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06671548to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Phase 3 · 1 location(s) · JW Pharmaceutical · NCT07378098Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia
Phase 2 · 1 location(s) · Shenzhen Kangzhe Biotechnology Co., Ltd. · NCT07402369A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uteri
Phase 3 · 120 location(s) · Sumitomo Pharma Switzerland GmbH · NCT05862272
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.